Swanton Robert Charles
SEC Form 4 insider trading activity
Swanton Robert Charles has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Oct 6, 2026.
On the most recent filing, Swanton Robert Charles is listed as Director at BICYCLE THERAPEUTICS PLC. Inside the rolling window, Swanton Robert Charles reported no open-market purchases and 1 open-market sale totaling $12K in BCYC.
Companies traded
Other insiders at BCYC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$12K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 2, 2025 | BCYC | Sale | $872 |
Frequently asked questions
How many SEC Form 4 filings has Swanton Robert Charles made?
Swanton Robert Charles has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Swanton Robert Charles trade?
Swanton Robert Charles has filed SEC Form 4 disclosures for 1 company, including BCYC.
When was Swanton Robert Charles's most recent SEC Form 4 filing?
Swanton Robert Charles's most recent SEC Form 4 filing on Tracefour is dated Oct 6, 2026.
What is Swanton Robert Charles's total buy and sell value in the current window?
Inside the rolling retention window, Swanton Robert Charles bought $0 and sold $12K based on SEC Form 4 filings.
What was Swanton Robert Charles's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,431 BCYC shares on 2026-10-02, worth $12K, per SEC Form 4 filings.